We invite you to participate in an open-label pilot study that explores the potential of Transcranial Magnetic Stimulation (TMS) to reduce the reliance on pain medication in people suffering from neuropathic pain.
Neuropathic pain stems from nerve damage, which disrupts the brain’s pain pathways and can make conventional treatments, like medication, ineffective. Millions of people struggle with this type of chronic pain, and the treatments they rely on often provide only temporary relief. Some even face the added challenge of medication dependence.
This study aims to offer an alternative through TMS, a non-invasive, FDA-approved therapy that has shown promise in targeting the neural pathways involved in pain—without the need for surgery or additional medications.
Transcranial Magnetic Stimulation (TMS) is a non-invasive, FDA-approved treatment that uses magnetic pulses to stimulate specific areas of the brain. Unlike other therapies that require surgery or medications, TMS directly targets the neural circuits involved in pain, offering potential long-term relief without the complications of more invasive treatments.
Fill out the form below to get started on this free trial and take the first step toward reducing your reliance on pain medications.
The primary goal of this pilot study is to evaluate how TMS can reduce the use of pain medication in individuals with chronic neuropathic pain. We will track your pain levels, medication use, and overall quality of life through questionnaires and weekly logs.
We are recruiting 10 participants for this open-label pilot study on the use of TMS to help reduce dependency on pain medications in individuals with chronic neuropathic pain.
Duration
The study involves 25 TMS sessions spread over 9 weeks.
Schedule:
Week 1–2: Five sessions per week.
Week 3–6: Three sessions per week.
Week 7–9: One session per week.
Who can participate?
We are seeking individuals who meet the following criteria:
Age: 21 years or older.
Chronic Neuropathic Pain: You have been diagnosed with chronic neuropathic pain for at least 6 months.
Pain Medication Use: You are currently taking pain medication as prescribed by a healthcare provider.
Commitment: Willingness to attend regular TMS sessions and track pain and medication use.
Treatment
Each session targets specific areas of the brain, with adjustments based on your response to the therapy.
We will track your pain levels and medication use throughout the study.
Exclusion Criteria
TMS, or Transcranial Magnetic Stimulation, is a non-invasive therapy that uses magnetic pulses to stimulate areas of the brain involved in pain processing. It’s FDA-approved and has been successfully used to treat medication-resistant depression, with growing evidence for its use in managing chronic pain.
TMS is considered very safe, with minimal side effects, such as mild headache or scalp discomfort after treatment. These effects typically resolve on their own within a few hours.
No, you will continue your prescribed medications, but we will track your medication usage to assess any changes in dosage throughout the study.
Each TMS session lasts about 30-40 minutes. You’ll be able to return to your daily activities immediately afterward.
Step 1: Fill out the short form below to see if you qualify.
Step 2: Consultation with a neurologist to confirm your eligibility.
Step 3: Begin your TMS sessions and start tracking your progress.
©2023 Piedmont Neuroscience Center. All rights reserved. Privacy Policy